→
Investors should consider the mixed signals from CME Group's growth metrics and premium valuation when evaluating their positions.
CME Group Inc. has a market capitalization of $101.12B and a current stock price of $280.66, reflecting a 1.21% increase from the previous close of $277.30. The P/E ratio stands at 25.15, while the dividend yield is 3.89%. Year-over-year EPS growth is reported at 15.41%, accompanied by a revenue growth of 6.37%. The stock's 52-week range shows a high of $329.01 and a low of $218.31.
Some investors cite CME Group's recent expansion into the U.S. zinc futures market, which may enhance revenue streams and market position. Additionally, the company's 15.41% EPS growth year-over-year indicates strong profitability potential amidst industry expansion.
Concerns have been raised regarding CME Group's stock trading at a premium, with a P/E ratio of 25.15, which may suggest overvaluation compared to peers. Furthermore, the stock's 52-week high of $329.01 raises questions about future growth sustainability after its considerable run-up of 67%.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly. Free to start.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
CME Group Inc. has a market capitalization of $101.12B and a current stock price of $280.66, reflecting a 1.21% increase from the previous close of $277.30. The P/E ratio stands at 25.15, while the dividend yield is 3.89%. Year-over-year EPS growth is reported at 15.41%, accompanied by a revenue growth of 6.37%. The stock's 52-week range shows a high of $329.01 and a low of $218.31.
Concerns have been raised regarding CME Group's stock trading at a premium, with a P/E ratio of 25.15, which may suggest overvaluation compared to peers. Furthermore, the stock's 52-week high of $329.01 raises questions about future growth sustainability after its considerable run-up of 67%.
Some investors cite CME Group's recent expansion into the U.S. zinc futures market, which may enhance revenue streams and market position. Additionally, the company's 15.41% EPS growth year-over-year indicates strong profitability potential amidst industry expansion.
Some investors cite CME Group's recent expansion into the U.S. zinc futures market, which may enhance revenue streams and market position. Additionally, the company's 15.41% EPS growth year-over-year indicates strong profitability potential amidst industry expansion. Concerns have been raised regarding CME Group's stock trading at a premium, with a P/E ratio of 25.15, which may suggest overvaluation compared to peers. Furthermore, the stock's 52-week high of $329.01 raises questions about future growth sustainability after its considerable run-up of 67%.
CME Group Inc. has a market capitalization of $101.12B and a current stock price of $280.66, reflecting a 1.21% increase from the previous close of $277.30. The P/E ratio stands at 25.15, while the dividend yield is 3.89%. Year-over-year EPS growth is reported at 15.41%, accompanied by a revenue growth of 6.37%. The stock's 52-week range shows a high of $329.01 and a low of $218.31.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for CME at helmterminal.dev/analyze/CME, updated continuously during US market hours. No signup required.